secwatch / observer
8-K filed June 13, 2023, 7:59 PM ET ticker SAIC CIK 0001571123
other material confidence high sentiment neutral materiality 0.50

SAIC stockholders approve new equity incentive plan and amended ESPP at 2023 annual meeting

Science Applications International Corp

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Science Applications International Corp shareholders approved Approval of the Science Applications International Corporation 2023 Equity Incentive Plan at the 2023-06-07 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-06-07
Exact text from the filing
4. The proposal to approve the 2023 Plan was approved based upon the following votes: Number of Votes For Against Abstain Broker Non-Votes 40,769,176 970,154 156,729 3,689,745
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Science Applications International Corp shareholders approved Approval, on a non-binding, advisory basis, of the compensation of the named executive officers at the 2023-06-07 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-06-07
Exact text from the filing
2. The proposal to approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company’s Proxy Statement (or a say-on-pay vote) was approved based upon the following votes: Number of Votes For Against Abstain Broker Non-Votes 39,380,463 2,288,213 227,383 3,689,745
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Science Applications International Corp shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending February 2, 2024 at the 2023-06-07 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-07
Exact text from the filing
3. The proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 2, 2024 was approved based upon the following votes: Number of Votes For Against Abstain 45,364,838 134,340 86,626
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Science Applications International Corp shareholders approved Approval of the Amended and Restated 2013 Employee Stock Purchase Plan at the 2023-06-07 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-06-07
Exact text from the filing
5. The proposal to approve the Amended and Restated 2013 Plan was approved based upon the following votes: Number of Votes For Against Abstain Broker Non-Votes 41,563,036 217,497 115,526 3,689,745
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Science Applications International Corp shareholders approved Election of Directors at the 2023-06-07 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-07
Exact text from the filing
1. The nominees to the Board of Directors of the Company were elected, each for a one-year term, based upon the following votes: Number of Votes Director Nominee For Against Abstain Broker Non-Votes Garth N. Graham 41,051,221 752,592 92,246 3,689,745 Carolyn B. Handlon 41,610,511 196,837 88,711 3,689,745 Yvette M. Kanouff 41,343,363 458,785 93,911 3,689,745 Nazzic S. Keene 41,590,060 220,931 85,068 3,689,745 Timothy J. Mayopoulos 41,386,487 409,475 100,097 3,689,745 Katharina G. McFarland 41,061,682 755,207 79,170 3,689,745 Milford W. McGuirt 41,031,151 759,273 105,635 3,689,745 Donna S. Morea 39,224,951 2,566,982 104,126 3,689,745 James C. Reagan 41,448,243 350,724 97,092 3,689,745 Steven R. Shane 41,335,073 475,816 85,170 3,689,745
View on SEC.gov

224 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Science Applications International Corp filing history →

Source: SEC EDGAR
accession 0001571123-23-000102
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.